Abcam plc (“Abcam”, “the Company” or “the Group”) (AIM LSE: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, made an announcement on August 2nd that it has entered into a definitive agreement to acquire BioVision, Inc. (“BioVision”), a wholly owned subsidiary of Boai NKY Medical Holdings Ltd. (“NKY”), for $340 million.
On March 1st 2021, Actblue Co., Ltd. (listed in A shares in China, ticker: 300816, hereinafter referred to as "Actblue") announced that it signed the "Put Option Agreement" with Vitesco Technologies Lohmar Verwaltungs GmbH (hereinafter referred to as "Continental VT Lohmar"). Actblue intends to acquire 100% of the shares of Vitesco Technologies Faulquemont SAS (hereinafter referred to as "Continental VT FQM") and other assets
On 29th May, Grammer AG (Grammer) announced the signing of a comprehensive Business Combination Agreement with affiliated companies of Ningbo Jifeng ("Jifeng"), under which Jifeng will make a voluntary public takeover offer for all outstanding shares of Grammer. The total consideration of 61.25 Euro per share (or US$ 889 million in total valuation) represents a premium of 19.4% over the closing price on the previous day,
Grammer AG (“Grammer”), Shentou’s client, has signed a contract to acquire 100% share of Toledo Molding & Die Inc. (“TMD”). Based in Toledo, Ohio, Unite States, the TMD Group specializes in development and production of thermoplastic products and applications mainly for vehicle interiors for automotive and automotive supply industries. According to preliminary figures, TMD generated revenue of more than $300 million in the financial year 2017, consisting of 11 facilities in the United States and Mexico with approx. 1600 employees.
In 2017, Shentou worked as the M&A consultant for Grammer AG by assisting Grammer to issue a 10% Mandatory Convertible Bond to Ningbo Jifeng, and advised further M&A activities of GRAMMER
Set up a joint-venture company YC Europe with Yuchai Group in Europe.
2014CONTACT INFO
1305, Jindi Century Building Tower A
Qiaoxiang Road
Shenzhen, 518053
P.R.China
Tel: +86-755-2389 5046
Email: contact@shentoucapital.com
Copyright Shentou Corporation,All Rights Reserved.
Support:Darkeye AD